Given Imaging Continues to Execute
Written by: Aaron Katsman | June 27, 2007
By Aaron Katsman
www.IsraelNewsletter.com
It’s been quite a week for Given Imaging (GIVN) shareholders. The week started off with the BooYa man himself Jim Cramer recommending the stock, and then today’s news that the Japanese central health insurance committee will reimburse patients who use the PillCam for diagnosis of abdominal symptoms. This is a huge win for the company as Japan is, by most accounts, the second biggest healthcare market in the world.
This win proves what I posted on the company a month ago, that Given Imaging has successfully begun to execute their business plan. Since that posting on the 15th of May, the stock has risen more than 15%, and like Cramer, I believe that this is one of the most exciting long-term Israeli plays out there. Keep in mind potential short-term volatility in the stock caused by profit takers as well as the fact that the local Tel Aviv stock exchange has a habit of poorly performing during July. With that in mind, any weakness should be used as a buying opportunity.
Disclosure: Author’s fund is long GIVN as of 6/27/07.
Please see our Disclaimer HERE.
Like what you see? Sign up to receive daily updates from IsraelNewsletter here
Aaron Katsman is the lead portfolio manager for the Israel Growth Portfolio and Managing Director of America Israel Investment Associates, LLC. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email aaron@profile-financial.com.
Share with others:
